Qodia raises €1.2M to automate AI billing under Germany's private medical fee schedule

Qodia (Hamburg) has raised €1.2 million from a single investor from the medical industry — whose identity was withheld at their request — bringing total funding to €1.6 million including a prior €400,000 seed investment in 2025. The company was founded in 2025 by Nicolas Riegger and Ole Reinpold (business), with Stephan Lenert and Lasse Reinpold leading software and AI development. Qodia builds AI-powered private medical billing software for the German GOÄ (Gebührenordnung für Ärzte) fee schedule.

What the GOÄ demands and why it matters for AI

The GOÄ is Germany's statutory fee schedule for private medical billing. It contains more than 2,800 billing codes, each governed by a combination of specialty rules, surcharge multipliers, exclusion clauses, and procedure-bundling logic. A dermatologist billing for an office visit alongside a minor surgical procedure faces different code combinations than a cardiologist running the same pairing; the rules are not intuitive, and they are not documented in a single accessible reference.

Billing centres — specialist firms that handle private billing on behalf of medical practices — exist because the complexity exceeds what most clinicians can manage alongside patient care. Their work involves three distinct tasks: verifying that a physician's invoice uses the correct codes and surcharges; translating clinical documentation (written in natural language) into billable GOÄ codes; and answering rules questions from practices that want to bill correctly before they submit.

Qodia has built AI tools for all three: an invoice verification module that flags exclusions, missing codes, and surcharge errors; a documentation translator that converts clinical notes into GOÄ code combinations; and a GOÄ assistant that answers rules questions against a proprietary database of all 2,800-plus codes. By May–June 2026, the company had added eight billing-centre clients in six weeks, reaching eleven total — rapid adoption for a B2B compliance tool in a conservative sector.

The investor structure and the distribution question

The round's single undisclosed investor from the medical industry is the structural detail that matters most. A medical-industry investor can mean several things: a billing-centre consolidator, a practice management software company, a healthcare IT provider, or a medical billing service firm. Any of those would bring distribution advantages that Qodia cannot buy with capital alone at this stage — access to billing-centre networks, integration partnerships with practice management systems, or co-selling arrangements with healthcare IT platforms.

Whether the investor brings those advantages is not disclosed. What is disclosed is the use of funds: advance automation of private medical billing and expand market presence — language consistent with a commercial acceleration rather than a technology build.

Scale and the next step

Total funding of €1.6 million across two rounds is lean for a regulated healthcare software company. Qodia's capacity to expand — into more billing centres, into other medical specialties, potentially into the successor GOÄ reform that German legislators have been debating — depends on whether the current eleven billing centres generate enough recurring revenue to fund growth, or whether a second institutional raise is required. The eleven-client, six-week adoption sprint is the most concrete evidence that demand is real. The 18-month question is whether that sprint translates into retention — billing centres that stay, use the product daily, and generate the gross margin that makes the next phase self-funding.